David Nicholas Gee - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Role: Chief Marketing Officer
Signature: /s/ David Gee
Issuer symbol: CLBT
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 08:14:59 UTC
SEC: View on sec.gov

Quoteable Key Fact

"David Nicholas Gee filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026."

Quick Takeaways

This page summarizes David Nicholas Gee's Form 3 filing for Cellebrite DI Ltd. (CLBT).
0 reported transactions and 1 derivative row are listed below.
Filing timestamp: 18 Mar 2026, 08:14.

What Changed

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GEE DAVID NICHOLAS	Chief Marketing Officer	94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL	/s/ David Gee	18 Mar 2026	0001547134

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLBT	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")						147,933	18 Mar 2026	Direct	F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLBT	Stock options							18 Mar 2026	Ordinary Shares	86,730	$11.53	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 51,057 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on May 20, 2024, of which 5,673 vest on each of May 20, 2026 and every three months thereafter through May 20, 2028. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
F2	Includes 7,836 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 653 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.
F3	Includes 22,694 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on May 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through May 20, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.
F4	Includes 66,346 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 16,594 vest on the one year anniversary of the grant date and 4,146 vest every three months thereafter through February 10, 2030.
F5	Of these stock options, 37,950 are fully vested and exercisable and 5,420 vest on each of May 20, 2026 and every three months thereafter through May 20, 2028.